07-01-2025
04:31 AM
HMPV Virus has surged in China. After COVID-19, human metapneumovirus (HMPV) has sparked a health crisis alarm and causes flu-like symptoms along with respiratory issues especially in children and vulnerable groups like elders and people with weak immune systems.
Discovered in 2001, Human Metapneumovirus (HMPV) is part of the Pneumoviridae family, which also includes the respiratory syncytial virus (RSV), as per the US Centers for Disease Control and Prevention (CDC). It typically causes respiratory infections, ranging from mild upper respiratory symptoms to more severe lower respiratory illnesses, resembling the common cold or flu.
HMPV affects individuals of all age groups, but young children, the elderly, and those with weakened immune systems are particularly vulnerable according to CDC.
Symptoms associated with HPMV include:
HPMV Virus can spread in the following ways:
Currently there is no specific vaccine or antiviral drug to treat HPMV Vaccine.To minimize the risk of HMPV and other respiratory illnesses, the following precautions are advised:
Q1. What is HMPV virus?
Ans. Human Metapneumovirus (HMPV) is a respiratory virus that causes upper and lower respiratory tract infections.
Q2. What are hMPV virus symptoms?
Ans. Symptoms include cough, fever, nasal congestion, sore throat, wheezing, and difficulty breathing, resembling a cold or flu.
Q3. Is human metapneumovirus highly contagious?
Ans. Yes, HMPV is highly contagious and spreads through respiratory droplets, close contact, or contaminated surfaces.
Q4. Who is at risk by this HMPV virus?
Ans. Young children, the elderly, and individuals with weakened immune systems are most at risk.
Q5. Which vaccine to get for HMPV virus?
Ans. Currently, there is no vaccine available for HMPV; preventive measures focus on hygiene and infection control.
© 2025 Vajiram & Ravi. All rights reserved